Federico Grossi - 28 Jan 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Tax liability	$25,084	-650	-0.62%	$38.59	103,941	28 Jan 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This represents shares used to cover tax withholding on a Restricted Stock Unit release.